Request for Covid-19 Impact Assessment of this Report
The United States Androgen and Anabolic Steroid market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Androgen and Anabolic Steroid market, reaching US$ million by the year 2028. As for the Europe Androgen and Anabolic Steroid landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Androgen and Anabolic Steroid players cover Auxilium Pharmaceuticals, AbbVie, Teva, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Androgen and Anabolic Steroid market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Testosterone
Methyltestosterone
Fluoxymesterone
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Auxilium Pharmaceuticals
AbbVie
Teva
GlaxoSmithKline
Endo Pharmaceuticals
Pfizer
Acerus Pharmaceuticals
Antares Pharma
Amneal Pharmaceuticals
Solvay Pharmaceuticals
Bausch Health
Pharmacia and Upjohn
Upsher-Smith
Clarus Therapeutics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Androgen and Anabolic Steroid Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Androgen and Anabolic Steroid by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Androgen and Anabolic Steroid by Country/Region, 2017, 2022 & 2028
2.2 Androgen and Anabolic Steroid Segment by Type
2.2.1 Testosterone
2.2.2 Methyltestosterone
2.2.3 Fluoxymesterone
2.2.4 Others
2.3 Androgen and Anabolic Steroid Sales by Type
2.3.1 Global Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)
2.3.2 Global Androgen and Anabolic Steroid Revenue and Market Share by Type (2017-2022)
2.3.3 Global Androgen and Anabolic Steroid Sale Price by Type (2017-2022)
2.4 Androgen and Anabolic Steroid Segment by Application
2.4.1 Hospitals
2.4.2 Pharmacy
2.4.3 Others
2.5 Androgen and Anabolic Steroid Sales by Application
2.5.1 Global Androgen and Anabolic Steroid Sale Market Share by Application (2017-2022)
2.5.2 Global Androgen and Anabolic Steroid Revenue and Market Share by Application (2017-2022)
2.5.3 Global Androgen and Anabolic Steroid Sale Price by Application (2017-2022)
3 Global Androgen and Anabolic Steroid by Company
3.1 Global Androgen and Anabolic Steroid Breakdown Data by Company
3.1.1 Global Androgen and Anabolic Steroid Annual Sales by Company (2020-2022)
3.1.2 Global Androgen and Anabolic Steroid Sales Market Share by Company (2020-2022)
3.2 Global Androgen and Anabolic Steroid Annual Revenue by Company (2020-2022)
3.2.1 Global Androgen and Anabolic Steroid Revenue by Company (2020-2022)
3.2.2 Global Androgen and Anabolic Steroid Revenue Market Share by Company (2020-2022)
3.3 Global Androgen and Anabolic Steroid Sale Price by Company
3.4 Key Manufacturers Androgen and Anabolic Steroid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Androgen and Anabolic Steroid Product Location Distribution
3.4.2 Players Androgen and Anabolic Steroid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Androgen and Anabolic Steroid by Geographic Region
4.1 World Historic Androgen and Anabolic Steroid Market Size by Geographic Region (2017-2022)
4.1.1 Global Androgen and Anabolic Steroid Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Androgen and Anabolic Steroid Annual Revenue by Geographic Region
4.2 World Historic Androgen and Anabolic Steroid Market Size by Country/Region (2017-2022)
4.2.1 Global Androgen and Anabolic Steroid Annual Sales by Country/Region (2017-2022)
4.2.2 Global Androgen and Anabolic Steroid Annual Revenue by Country/Region
4.3 Americas Androgen and Anabolic Steroid Sales Growth
4.4 APAC Androgen and Anabolic Steroid Sales Growth
4.5 Europe Androgen and Anabolic Steroid Sales Growth
4.6 Middle East & Africa Androgen and Anabolic Steroid Sales Growth
5 Americas
5.1 Americas Androgen and Anabolic Steroid Sales by Country
5.1.1 Americas Androgen and Anabolic Steroid Sales by Country (2017-2022)
5.1.2 Americas Androgen and Anabolic Steroid Revenue by Country (2017-2022)
5.2 Americas Androgen and Anabolic Steroid Sales by Type
5.3 Americas Androgen and Anabolic Steroid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgen and Anabolic Steroid Sales by Region
6.1.1 APAC Androgen and Anabolic Steroid Sales by Region (2017-2022)
6.1.2 APAC Androgen and Anabolic Steroid Revenue by Region (2017-2022)
6.2 APAC Androgen and Anabolic Steroid Sales by Type
6.3 APAC Androgen and Anabolic Steroid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Androgen and Anabolic Steroid by Country
7.1.1 Europe Androgen and Anabolic Steroid Sales by Country (2017-2022)
7.1.2 Europe Androgen and Anabolic Steroid Revenue by Country (2017-2022)
7.2 Europe Androgen and Anabolic Steroid Sales by Type
7.3 Europe Androgen and Anabolic Steroid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Androgen and Anabolic Steroid by Country
8.1.1 Middle East & Africa Androgen and Anabolic Steroid Sales by Country (2017-2022)
8.1.2 Middle East & Africa Androgen and Anabolic Steroid Revenue by Country (2017-2022)
8.2 Middle East & Africa Androgen and Anabolic Steroid Sales by Type
8.3 Middle East & Africa Androgen and Anabolic Steroid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Androgen and Anabolic Steroid
10.3 Manufacturing Process Analysis of Androgen and Anabolic Steroid
10.4 Industry Chain Structure of Androgen and Anabolic Steroid
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Androgen and Anabolic Steroid Distributors
11.3 Androgen and Anabolic Steroid Customer
12 World Forecast Review for Androgen and Anabolic Steroid by Geographic Region
12.1 Global Androgen and Anabolic Steroid Market Size Forecast by Region
12.1.1 Global Androgen and Anabolic Steroid Forecast by Region (2023-2028)
12.1.2 Global Androgen and Anabolic Steroid Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Androgen and Anabolic Steroid Forecast by Type
12.7 Global Androgen and Anabolic Steroid Forecast by Application
13 Key Players Analysis
13.1 Auxilium Pharmaceuticals
13.1.1 Auxilium Pharmaceuticals Company Information
13.1.2 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Offered
13.1.3 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Auxilium Pharmaceuticals Main Business Overview
13.1.5 Auxilium Pharmaceuticals Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Androgen and Anabolic Steroid Product Offered
13.2.3 AbbVie Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Androgen and Anabolic Steroid Product Offered
13.3.3 Teva Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Androgen and Anabolic Steroid Product Offered
13.4.3 GlaxoSmithKline Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 Endo Pharmaceuticals
13.5.1 Endo Pharmaceuticals Company Information
13.5.2 Endo Pharmaceuticals Androgen and Anabolic Steroid Product Offered
13.5.3 Endo Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Endo Pharmaceuticals Main Business Overview
13.5.5 Endo Pharmaceuticals Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Androgen and Anabolic Steroid Product Offered
13.6.3 Pfizer Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Acerus Pharmaceuticals
13.7.1 Acerus Pharmaceuticals Company Information
13.7.2 Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Offered
13.7.3 Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Acerus Pharmaceuticals Main Business Overview
13.7.5 Acerus Pharmaceuticals Latest Developments
13.8 Antares Pharma
13.8.1 Antares Pharma Company Information
13.8.2 Antares Pharma Androgen and Anabolic Steroid Product Offered
13.8.3 Antares Pharma Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Antares Pharma Main Business Overview
13.8.5 Antares Pharma Latest Developments
13.9 Amneal Pharmaceuticals
13.9.1 Amneal Pharmaceuticals Company Information
13.9.2 Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Offered
13.9.3 Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Amneal Pharmaceuticals Main Business Overview
13.9.5 Amneal Pharmaceuticals Latest Developments
13.10 Solvay Pharmaceuticals
13.10.1 Solvay Pharmaceuticals Company Information
13.10.2 Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Offered
13.10.3 Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Solvay Pharmaceuticals Main Business Overview
13.10.5 Solvay Pharmaceuticals Latest Developments
13.11 Bausch Health
13.11.1 Bausch Health Company Information
13.11.2 Bausch Health Androgen and Anabolic Steroid Product Offered
13.11.3 Bausch Health Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Bausch Health Main Business Overview
13.11.5 Bausch Health Latest Developments
13.12 Pharmacia and Upjohn
13.12.1 Pharmacia and Upjohn Company Information
13.12.2 Pharmacia and Upjohn Androgen and Anabolic Steroid Product Offered
13.12.3 Pharmacia and Upjohn Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Pharmacia and Upjohn Main Business Overview
13.12.5 Pharmacia and Upjohn Latest Developments
13.13 Upsher-Smith
13.13.1 Upsher-Smith Company Information
13.13.2 Upsher-Smith Androgen and Anabolic Steroid Product Offered
13.13.3 Upsher-Smith Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Upsher-Smith Main Business Overview
13.13.5 Upsher-Smith Latest Developments
13.14 Clarus Therapeutics
13.14.1 Clarus Therapeutics Company Information
13.14.2 Clarus Therapeutics Androgen and Anabolic Steroid Product Offered
13.14.3 Clarus Therapeutics Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Clarus Therapeutics Main Business Overview
13.14.5 Clarus Therapeutics Latest Developments
14 Research Findings and Conclusion
Table 1. Androgen and Anabolic Steroid Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Androgen and Anabolic Steroid Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Testosterone
Table 4. Major Players of Methyltestosterone
Table 5. Major Players of Fluoxymesterone
Table 6. Major Players of Others
Table 7. Global Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)
Table 8. Global Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)
Table 9. Global Androgen and Anabolic Steroid Revenue by Type (2017-2022) & ($ million)
Table 10. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2017-2022)
Table 11. Global Androgen and Anabolic Steroid Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)
Table 13. Global Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)
Table 14. Global Androgen and Anabolic Steroid Revenue by Application (2017-2022)
Table 15. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2017-2022)
Table 16. Global Androgen and Anabolic Steroid Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Androgen and Anabolic Steroid Sales by Company (2020-2022) & (K Units)
Table 18. Global Androgen and Anabolic Steroid Sales Market Share by Company (2020-2022)
Table 19. Global Androgen and Anabolic Steroid Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Androgen and Anabolic Steroid Revenue Market Share by Company (2020-2022)
Table 21. Global Androgen and Anabolic Steroid Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Androgen and Anabolic Steroid Producing Area Distribution and Sales Area
Table 23. Players Androgen and Anabolic Steroid Products Offered
Table 24. Androgen and Anabolic Steroid Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Androgen and Anabolic Steroid Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Androgen and Anabolic Steroid Sales Market Share Geographic Region (2017-2022)
Table 29. Global Androgen and Anabolic Steroid Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Androgen and Anabolic Steroid Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Androgen and Anabolic Steroid Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Androgen and Anabolic Steroid Sales Market Share by Country/Region (2017-2022)
Table 33. Global Androgen and Anabolic Steroid Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Androgen and Anabolic Steroid Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Androgen and Anabolic Steroid Sales by Country (2017-2022) & (K Units)
Table 36. Americas Androgen and Anabolic Steroid Sales Market Share by Country (2017-2022)
Table 37. Americas Androgen and Anabolic Steroid Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Androgen and Anabolic Steroid Revenue Market Share by Country (2017-2022)
Table 39. Americas Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)
Table 40. Americas Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)
Table 41. Americas Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)
Table 42. Americas Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)
Table 43. APAC Androgen and Anabolic Steroid Sales by Region (2017-2022) & (K Units)
Table 44. APAC Androgen and Anabolic Steroid Sales Market Share by Region (2017-2022)
Table 45. APAC Androgen and Anabolic Steroid Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Androgen and Anabolic Steroid Revenue Market Share by Region (2017-2022)
Table 47. APAC Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)
Table 48. APAC Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)
Table 49. APAC Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)
Table 50. APAC Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)
Table 51. Europe Androgen and Anabolic Steroid Sales by Country (2017-2022) & (K Units)
Table 52. Europe Androgen and Anabolic Steroid Sales Market Share by Country (2017-2022)
Table 53. Europe Androgen and Anabolic Steroid Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Androgen and Anabolic Steroid Revenue Market Share by Country (2017-2022)
Table 55. Europe Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)
Table 56. Europe Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)
Table 57. Europe Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)
Table 58. Europe Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Androgen and Anabolic Steroid Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Androgen and Anabolic Steroid Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Androgen and Anabolic Steroid Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Androgen and Anabolic Steroid
Table 68. Key Market Challenges & Risks of Androgen and Anabolic Steroid
Table 69. Key Industry Trends of Androgen and Anabolic Steroid
Table 70. Androgen and Anabolic Steroid Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Androgen and Anabolic Steroid Distributors List
Table 73. Androgen and Anabolic Steroid Customer List
Table 74. Global Androgen and Anabolic Steroid Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Androgen and Anabolic Steroid Sales Market Forecast by Region
Table 76. Global Androgen and Anabolic Steroid Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Androgen and Anabolic Steroid Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Androgen and Anabolic Steroid Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Androgen and Anabolic Steroid Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Androgen and Anabolic Steroid Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Androgen and Anabolic Steroid Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Androgen and Anabolic Steroid Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Androgen and Anabolic Steroid Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Androgen and Anabolic Steroid Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Androgen and Anabolic Steroid Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Androgen and Anabolic Steroid Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Androgen and Anabolic Steroid Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Androgen and Anabolic Steroid Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Androgen and Anabolic Steroid Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Androgen and Anabolic Steroid Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Androgen and Anabolic Steroid Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Androgen and Anabolic Steroid Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Androgen and Anabolic Steroid Revenue Market Share Forecast by Application (2023-2028)
Table 94. Auxilium Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 95. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Offered
Table 96. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Auxilium Pharmaceuticals Main Business
Table 98. Auxilium Pharmaceuticals Latest Developments
Table 99. AbbVie Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 100. AbbVie Androgen and Anabolic Steroid Product Offered
Table 101. AbbVie Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. AbbVie Main Business
Table 103. AbbVie Latest Developments
Table 104. Teva Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 105. Teva Androgen and Anabolic Steroid Product Offered
Table 106. Teva Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Teva Main Business
Table 108. Teva Latest Developments
Table 109. GlaxoSmithKline Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 110. GlaxoSmithKline Androgen and Anabolic Steroid Product Offered
Table 111. GlaxoSmithKline Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. GlaxoSmithKline Main Business
Table 113. GlaxoSmithKline Latest Developments
Table 114. Endo Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 115. Endo Pharmaceuticals Androgen and Anabolic Steroid Product Offered
Table 116. Endo Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Endo Pharmaceuticals Main Business
Table 118. Endo Pharmaceuticals Latest Developments
Table 119. Pfizer Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Androgen and Anabolic Steroid Product Offered
Table 121. Pfizer Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Acerus Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 125. Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Offered
Table 126. Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Acerus Pharmaceuticals Main Business
Table 128. Acerus Pharmaceuticals Latest Developments
Table 129. Antares Pharma Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 130. Antares Pharma Androgen and Anabolic Steroid Product Offered
Table 131. Antares Pharma Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Antares Pharma Main Business
Table 133. Antares Pharma Latest Developments
Table 134. Amneal Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 135. Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Offered
Table 136. Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Amneal Pharmaceuticals Main Business
Table 138. Amneal Pharmaceuticals Latest Developments
Table 139. Solvay Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 140. Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Offered
Table 141. Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Solvay Pharmaceuticals Main Business
Table 143. Solvay Pharmaceuticals Latest Developments
Table 144. Bausch Health Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 145. Bausch Health Androgen and Anabolic Steroid Product Offered
Table 146. Bausch Health Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Bausch Health Main Business
Table 148. Bausch Health Latest Developments
Table 149. Pharmacia and Upjohn Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 150. Pharmacia and Upjohn Androgen and Anabolic Steroid Product Offered
Table 151. Pharmacia and Upjohn Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Pharmacia and Upjohn Main Business
Table 153. Pharmacia and Upjohn Latest Developments
Table 154. Upsher-Smith Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 155. Upsher-Smith Androgen and Anabolic Steroid Product Offered
Table 156. Upsher-Smith Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Upsher-Smith Main Business
Table 158. Upsher-Smith Latest Developments
Table 159. Clarus Therapeutics Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors
Table 160. Clarus Therapeutics Androgen and Anabolic Steroid Product Offered
Table 161. Clarus Therapeutics Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Clarus Therapeutics Main Business
Table 163. Clarus Therapeutics Latest Developments
List of Figures
Figure 1. Picture of Androgen and Anabolic Steroid
Figure 2. Androgen and Anabolic Steroid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Androgen and Anabolic Steroid Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Androgen and Anabolic Steroid Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Androgen and Anabolic Steroid Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Testosterone
Figure 10. Product Picture of Methyltestosterone
Figure 11. Product Picture of Fluoxymesterone
Figure 12. Product Picture of Others
Figure 13. Global Androgen and Anabolic Steroid Sales Market Share by Type in 2021
Figure 14. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2017-2022)
Figure 15. Androgen and Anabolic Steroid Consumed in Hospitals
Figure 16. Global Androgen and Anabolic Steroid Market: Hospitals (2017-2022) & (K Units)
Figure 17. Androgen and Anabolic Steroid Consumed in Pharmacy
Figure 18. Global Androgen and Anabolic Steroid Market: Pharmacy (2017-2022) & (K Units)
Figure 19. Androgen and Anabolic Steroid Consumed in Others
Figure 20. Global Androgen and Anabolic Steroid Market: Others (2017-2022) & (K Units)
Figure 21. Global Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)
Figure 22. Global Androgen and Anabolic Steroid Revenue Market Share by Application in 2021
Figure 23. Androgen and Anabolic Steroid Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Androgen and Anabolic Steroid Revenue Market Share by Company in 2021
Figure 25. Global Androgen and Anabolic Steroid Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Androgen and Anabolic Steroid Revenue Market Share by Geographic Region in 2021
Figure 27. Global Androgen and Anabolic Steroid Sales Market Share by Region (2017-2022)
Figure 28. Global Androgen and Anabolic Steroid Revenue Market Share by Country/Region in 2021
Figure 29. Americas Androgen and Anabolic Steroid Sales 2017-2022 (K Units)
Figure 30. Americas Androgen and Anabolic Steroid Revenue 2017-2022 ($ Millions)
Figure 31. APAC Androgen and Anabolic Steroid Sales 2017-2022 (K Units)
Figure 32. APAC Androgen and Anabolic Steroid Revenue 2017-2022 ($ Millions)
Figure 33. Europe Androgen and Anabolic Steroid Sales 2017-2022 (K Units)
Figure 34. Europe Androgen and Anabolic Steroid Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Androgen and Anabolic Steroid Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Androgen and Anabolic Steroid Revenue 2017-2022 ($ Millions)
Figure 37. Americas Androgen and Anabolic Steroid Sales Market Share by Country in 2021
Figure 38. Americas Androgen and Anabolic Steroid Revenue Market Share by Country in 2021
Figure 39. United States Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Androgen and Anabolic Steroid Sales Market Share by Region in 2021
Figure 44. APAC Androgen and Anabolic Steroid Revenue Market Share by Regions in 2021
Figure 45. China Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Androgen and Anabolic Steroid Sales Market Share by Country in 2021
Figure 52. Europe Androgen and Anabolic Steroid Revenue Market Share by Country in 2021
Figure 53. Germany Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Androgen and Anabolic Steroid Revenue Market Share by Country in 2021
Figure 60. Egypt Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Androgen and Anabolic Steroid in 2021
Figure 66. Manufacturing Process Analysis of Androgen and Anabolic Steroid
Figure 67. Industry Chain Structure of Androgen and Anabolic Steroid
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...